Technical Analysis for EDAP - EDAP TMS S.A.

Grade Last Price % Change Price Change
C 7.26 -3.20% -0.24
EDAP closed down 3.2 percent on Monday, March 18, 2024, on 23 percent of normal volume.
Earnings due: Mar 27
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -3.20%
Wide Bands Range Expansion -1.49%
Wide Bands Range Expansion -3.63%
Gapped Down Weakness -3.63%
Calm After Storm Range Contraction -2.42%
Outside Day Range Expansion -2.42%
Wide Bands Range Expansion -2.42%
Overbought Stochastic Strength -2.42%
Calm After Storm Range Contraction -1.76%

   Recent Intraday Alerts

Alert Time
Down 3% about 18 hours ago
Fell Below Previous Day's Low about 19 hours ago
Down 2 % about 19 hours ago
60 Minute Opening Range Breakdown about 20 hours ago
10 DMA Resistance about 20 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

EDAP TMS S.A. Description

EDAP TMS S.A., through its subsidiaries, engages in the development, production, marketing, distribution, and maintenance of minimally invasive medical devices for the treatment of urological diseases. The company operates in two divisions, High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division offers medical devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. This division provides Ablatherm, a HIFU-based ultrasound guided device for the treatment of organ-confined prostate cancer. Its HIFU technology allows the surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division also engages in the leasing of equipment, as well as the sale of disposables, spare parts, and maintenance services. It markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. The UDS division provides medical devices for the minimally invasive diagnosis or treatment of urological disorders, primarily urinary stones and other clinical indications. This division manufactures lithotripters, including the Sonolith i-move and the Sonolith i-sys, for the treatment of urinary tract stones by means of ESWL technology. It is also involved in the leasing of lithotripters, as well as the sale of disposables, spare parts, and maintenance services. This division markets and sells its products through its direct sales and service platform, as well as through agents and third-party distributors. The company's customers include public and private hospitals, urology clinics, and research institutions worldwide. EDAP TMS S.A. was founded in 1979 and is based in Vaulx-en-Velin, France.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinic Prostate Cancer Urology Direct Marketing Ultrasound Urological Disorders Magnetic Resonance Imaging Organs Lath Medical Ultrasonography Urological Diseases High Intensity Focused Ultrasound Invasive Medical Devices Localized Tumors Minimally Invasive Medical Devices

Is EDAP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.23
52 Week Low 3.6
Average Volume 37,921
200-Day Moving Average 6.98
50-Day Moving Average 6.39
20-Day Moving Average 6.86
10-Day Moving Average 7.49
Average True Range 0.39
RSI (14) 58.68
ADX 21.42
+DI 25.88
-DI 18.48
Chandelier Exit (Long, 3 ATRs) 6.81
Chandelier Exit (Short, 3 ATRs) 6.66
Upper Bollinger Bands 8.35
Lower Bollinger Band 5.36
Percent B (%b) 0.63
BandWidth 43.63
MACD Line 0.36
MACD Signal Line 0.34
MACD Histogram 0.0132
Fundamentals Value
Market Cap 268.09 Million
Num Shares 36.9 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -11.17
Price-to-Sales 4.18
Price-to-Book 3.62
PEG Ratio 90.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.75
Resistance 3 (R3) 7.80 7.69 7.67
Resistance 2 (R2) 7.69 7.56 7.66 7.64
Resistance 1 (R1) 7.47 7.48 7.42 7.42 7.62
Pivot Point 7.36 7.36 7.33 7.33 7.36
Support 1 (S1) 7.14 7.23 7.09 7.10 6.90
Support 2 (S2) 7.03 7.15 7.00 6.88
Support 3 (S3) 6.81 7.03 6.85
Support 4 (S4) 6.77